Donald Yin

1.1k total citations
30 papers, 895 citations indexed

About

Donald Yin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Economics and Econometrics. According to data from OpenAlex, Donald Yin has authored 30 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 9 papers in Economics and Econometrics. Recurrent topics in Donald Yin's work include Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Donald Yin is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Donald Yin collaborates with scholars based in United States, France and United Kingdom. Donald Yin's co-authors include Vasilisa Sazonov Kocevar, E. Alemao, Panagiotis Mavros, Qiaoyi Zhang, J.R. Cook, David Price, Mike Thomas, A. Lawrence Gould, Glenn Davies and Ying Qiu and has published in prestigious journals such as Gastroenterology, Diabetes Care and PEDIATRICS.

In The Last Decade

Donald Yin

28 papers receiving 852 citations

Peers

Donald Yin
Erin R. Weeda United States
Désirée F. Jansen Netherlands
Stefan Vegter Netherlands
Lorenzo Pradelli Italy
Aristofanis Gikas Greece
Y Zopf Germany
Salvatore Mannino Italy
Jingwen Tan China
Ishak A. Mansi United States
Marcin Renke Poland
Erin R. Weeda United States
Donald Yin
Citations per year, relative to Donald Yin Donald Yin (= 1×) peers Erin R. Weeda

Countries citing papers authored by Donald Yin

Since Specialization
Citations

This map shows the geographic impact of Donald Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Yin more than expected).

Fields of papers citing papers by Donald Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Yin. The network helps show where Donald Yin may publish in the future.

Co-authorship network of co-authors of Donald Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Yin. A scholar is included among the top collaborators of Donald Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Yin. Donald Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Carson, Robyn T., Annie Guérin, Barbara Lewis, et al.. (2012). Su1194 Treatment Patterns and Indicators of Unmet Needs in Medicaid Patients With Irritable Bowel Syndrome With Constipation and Chronic Constipation. Gastroenterology. 142(5). S–448. 1 indexed citations
3.
Sun, Shawn X., Maryna Marynchenko, Ritesh Banerjee, et al.. (2011). Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD. Journal of Medical Economics. 14(6). 805–815. 10 indexed citations
4.
Fu, Alex Z., Ying Qiu, Larry Radican, Donald Yin, & Panagiotis Mavros. (2010). Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study. Cardiovascular Diabetology. 9(1). 15–15. 12 indexed citations
5.
Zhang, Qiaoyi, Panagiotis Mavros, Samuel S. Engel, et al.. (2010). Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database. Advances in Therapy. 27(4). 223–232. 8 indexed citations
6.
Guisasola, Fernando Álvarez, Donald Yin, G Nocea, Ying Qiu, & Panagiotis Mavros. (2010). Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study. Health and Quality of Life Outcomes. 8(1). 86–86. 66 indexed citations
7.
Gould, A. Lawrence, Glenn Davies, E. Alemao, Donald Yin, & J.R. Cook. (2007). Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clinical Therapeutics. 29(5). 778–794. 117 indexed citations
8.
Kohli, Michele, Cheryl Attard, Annette Lam, et al.. (2006). Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada. PharmacoEconomics. 24(8). 815–830. 18 indexed citations
9.
Phatak, Hemant & Donald Yin. (2006). Factors associated with the effect-size of thiazolidinedione (TZD) therapy on HbA1c:a meta-analysis of published randomized clinical trials. Current Medical Research and Opinion. 22(11). 2267–2278. 19 indexed citations
10.
Laforest, Laurent, et al.. (2006). Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy. Pediatric Allergy and Immunology. 17(8). 620–628. 7 indexed citations
11.
Rajagopalan, Srinivasan, José Luiz Lopes Vieira, E. Alemao, Donald Yin, & Emílio Hideyuki Moriguchi. (2006). The impact of lipid-lowering treatment patterns on LDL-C reduction and goal attainment in secondary prevention in Germany. Global Heart. 2(1). 15–15. 3 indexed citations
12.
Laforest, Laurent, Pierre Ernst, G. Pietri, et al.. (2005). Asthma-Related Costs Relative to Severity and Control in General Practice. Pediatric Asthma Allergy & Immunology. 18(1). 36–45. 5 indexed citations
13.
Luskin, Allan T., et al.. (2005). Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy. Annals of Allergy Asthma & Immunology. 95(2). 129–136. 9 indexed citations
14.
Laforest, Laurent, Jean Bousquet, G. Pietri, et al.. (2005). Quality of Life during Pollen Season in Patients with Seasonal Allergic Rhinitis with or without Asthma. International Archives of Allergy and Immunology. 136(3). 281–286. 50 indexed citations
15.
Meaney, Eduardo, et al.. (2005). [Cholesterol goal attainment with lipid lowering drugs. The COMETA Mexico Trial].. PubMed. 140(5). 493–501. 5 indexed citations
16.
Goettsch, Wim, Donald Yin, E. Alemao, et al.. (2004). Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study;. Current Medical Research and Opinion. 20(7). 1025–1033. 27 indexed citations
17.
Laforest, Laurent, Donald Yin, Vasilisa Sazonov Kocevar, et al.. (2004). Association between asthma control in children and loss of workdays by caregivers. Annals of Allergy Asthma & Immunology. 93(3). 265–271. 30 indexed citations
18.
Kocevar, Vasilisa Sazonov, Hans Bisgaard, Linus Jönsson, et al.. (2004). Variations in Pediatric Asthma Hospitalization Rates and Costs Between and Within Nordic Countries. CHEST Journal. 125(5). 1680–1684A. 53 indexed citations
19.
Tramarin, Andrea, Stefano Campostrini, Donald Yin, et al.. (2004). Association between diarrhea and quality of life in HIV-infected patients receiving highly active antiretroviral therapy. Quality of Life Research. 13(1). 243–250. 33 indexed citations
20.
Segal, Richard, et al.. (2004). Resource Use and Cost of Care for Patients Hospitalised with Community Acquired Pneumonia. PharmacoEconomics. 22(11). 751–757. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erin R. Weeda Breakdown of academic impact, for papers by Désirée F. Jansen Breakdown of academic impact, for papers by Stefan Vegter Breakdown of academic impact, for papers by Lorenzo Pradelli Breakdown of academic impact, for papers by Aristofanis Gikas Breakdown of academic impact, for papers by Y Zopf Breakdown of academic impact, for papers by Salvatore Mannino Breakdown of academic impact, for papers by Jingwen Tan Breakdown of academic impact, for papers by Ishak A. Mansi Breakdown of academic impact, for papers by Marcin Renke
Rankless by CCL
2026